163 related articles for article (PubMed ID: 32327706)
1. The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease.
Chen Y; Shao C; Fan NW; Nakao T; Amouzegar A; Chauhan SK; Dana R
Mucosal Immunol; 2021 Jan; 14(1):177-186. PubMed ID: 32327706
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity.
Chen Y; Chauhan SK; Tan X; Dana R
J Autoimmun; 2017 Feb; 77():96-103. PubMed ID: 27899224
[TBL] [Abstract][Full Text] [Related]
3. Chronic dry eye disease is principally mediated by effector memory Th17 cells.
Chen Y; Chauhan SK; Lee HS; Saban DR; Dana R
Mucosal Immunol; 2014 Jan; 7(1):38-45. PubMed ID: 23571503
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.
Chauhan SK; El Annan J; Ecoiffier T; Goyal S; Zhang Q; Saban DR; Dana R
J Immunol; 2009 Feb; 182(3):1247-52. PubMed ID: 19155469
[TBL] [Abstract][Full Text] [Related]
5. The pathogenicity of Th17 cells in autoimmune diseases.
Yasuda K; Takeuchi Y; Hirota K
Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
[TBL] [Abstract][Full Text] [Related]
6. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity.
Chen Y; Chauhan SK; Shao C; Omoto M; Inomata T; Dana R
J Immunol; 2017 Aug; 199(3):1163-1169. PubMed ID: 28637904
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23.
Haines CJ; Chen Y; Blumenschein WM; Jain R; Chang C; Joyce-Shaikh B; Porth K; Boniface K; Mattson J; Basham B; Anderton SM; McClanahan TK; Sadekova S; Cua DJ; McGeachy MJ
Cell Rep; 2013 May; 3(5):1378-88. PubMed ID: 23623497
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 Receptor E and C-C Motif Chemokine Receptor 10 Identify Heterogeneous T Helper 17 Subsets in a Mouse Dry Eye Disease Model.
Wang J; Gong J; Yang Q; Wang L; Jian Y; Wang P
Am J Pathol; 2022 Feb; 192(2):332-343. PubMed ID: 35144761
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in dry eye disease - An updated review of evidence on effector and memory Th17 cells in disease pathogenicity.
Chen Y; Dana R
Autoimmun Rev; 2021 Nov; 20(11):102933. PubMed ID: 34509656
[TBL] [Abstract][Full Text] [Related]
11. Autoreactive memory Th17 cells are principally derived from T-bet
Fan NW; Wang S; Ortiz G; Chauhan SK; Chen Y; Dana R
J Autoimmun; 2022 May; 129():102816. PubMed ID: 35395541
[TBL] [Abstract][Full Text] [Related]
12. A novel pro-lymphangiogenic function for Th17/IL-17.
Chauhan SK; Jin Y; Goyal S; Lee HS; Fuchsluger TA; Lee HK; Dana R
Blood; 2011 Oct; 118(17):4630-4. PubMed ID: 21908425
[TBL] [Abstract][Full Text] [Related]
13. Metabolic heterogeneity underlies reciprocal fates of T
Karmaus PWF; Chen X; Lim SA; Herrada AA; Nguyen TM; Xu B; Dhungana Y; Rankin S; Chen W; Rosencrance C; Yang K; Fan Y; Cheng Y; Easton J; Neale G; Vogel P; Chi H
Nature; 2019 Jan; 565(7737):101-105. PubMed ID: 30568299
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of IL-6 inhibits formation of autoreactive TH17 cells but does not prevent loss of renal function in experimental autoimmune glomerulonephritis.
Brede KM; Schmid J; Steinmetz OM; Panzer U; Klinge S; Mittrücker HW
Immunol Lett; 2021 Aug; 236():51-60. PubMed ID: 34015360
[TBL] [Abstract][Full Text] [Related]
15. Aged Mice Exhibit Severe Exacerbations of Dry Eye Disease with an Amplified Memory Th17 Cell Response.
Foulsham W; Mittal SK; Taketani Y; Chen Y; Nakao T; Chauhan SK; Dana R
Am J Pathol; 2020 Jul; 190(7):1474-1482. PubMed ID: 32289288
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation.
Yu M; Lee SM; Lee H; Amouzegar A; Nakao T; Chen Y; Dana R
Am J Pathol; 2020 Jan; 190(1):125-133. PubMed ID: 31669306
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling.
Raveney BJ; Oki S; Yamamura T
PLoS One; 2013; 8(2):e56595. PubMed ID: 23437182
[TBL] [Abstract][Full Text] [Related]
18. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
Luger D; Silver PB; Tang J; Cua D; Chen Z; Iwakura Y; Bowman EP; Sgambellone NM; Chan CC; Caspi RR
J Exp Med; 2008 Apr; 205(4):799-810. PubMed ID: 18391061
[TBL] [Abstract][Full Text] [Related]
19. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.
Kastirr I; Maglie S; Paroni M; Alfen JS; Nizzoli G; Sugliano E; Crosti MC; Moro M; Steckel B; Steinfelder S; Stölzel K; Romagnani C; Botti F; Caprioli F; Pagani M; Abrignani S; Geginat J
J Immunol; 2014 Oct; 193(7):3322-31. PubMed ID: 25172491
[TBL] [Abstract][Full Text] [Related]
20. miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases.
Huang J; Xu X; Yang J
Front Immunol; 2021; 12():593473. PubMed ID: 33968012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
